Orbital Therapeutics
4 known investors
A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.
BiotechHealthtechMedical Devices
Investors · 4
In the news
- Orbital Therapeutics Raises $300M in Series A Funding, Pioneering the Future of RNA Medicines | SignalBasetrysignalbase.com · 2025
- Beam Spin-Out Orbital Therapeutics Raises $270M to Advance RNA Portfolio - BioSpacebiospace.com · 2023
- Orbital Therapeutics Secures $270 Million in Series A Financing to Unleash Full Potential of RNA Medicines - Orbital Therapeutics | Orbital Therapeuticsorbitaltx.com · 2023
- Orbital Therapeutics Raises $270M in Series A Financingfinsmes.com · 2023
- Orbital bags $270 million to advance RNA-based therapeutics | FirstWord Pharmafirstwordpharma.com · 2023
- Orbital Therapeutics - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2023